SunTrust Banks, Inc. began coverage on shares of National Health Investors, Inc. (NYSE:NHI) in a report issued on Tuesday. The firm issued a hold rating and a $80.00 price target on the real estate investment trust’s stock.
A number of other equities research analysts have also recently weighed in on the company. Mizuho restated a neutral rating on shares of National Health Investors in a report on Wednesday, June 28th. Stifel Nicolaus upped their price target on National Health Investors from $80.00 to $82.00 and gave the stock a buy rating in a report on Wednesday, June 21st. Zacks Investment Research upgraded National Health Investors from a hold rating to a buy rating and set a $89.00 price target on the stock in a report on Friday, September 15th. BidaskClub cut National Health Investors from a buy rating to a hold rating in a report on Saturday, July 8th. Finally, KeyCorp restated a hold rating on shares of National Health Investors in a report on Sunday, September 17th. One analyst has rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the company’s stock. The stock currently has an average rating of Hold and a consensus target price of $80.17.
Shares of National Health Investors (NHI) traded up 0.25% during trading on Tuesday, reaching $77.36. The company’s stock had a trading volume of 16,012 shares. The company has a 50 day moving average price of $78.99 and a 200 day moving average price of $76.78. National Health Investors has a 52 week low of $66.31 and a 52 week high of $81.21. The firm has a market capitalization of $3.17 billion, a P/E ratio of 19.84 and a beta of 0.56.
National Health Investors (NYSE:NHI) last released its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share for the quarter, missing analysts’ consensus estimates of $1.29 by ($0.36). The firm had revenue of $69.84 million during the quarter, compared to analyst estimates of $67.68 million. National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. The business’s revenue was up 14.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.22 EPS. On average, equities research analysts expect that National Health Investors will post $3.85 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by Markets Daily and is the property of of Markets Daily. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at https://www.themarketsdaily.com/2017/10/11/national-health-investors-inc-nhi-receives-new-coverage-from-analysts-at-suntrust-banks-inc.html.
The business also recently announced a quarterly dividend, which will be paid on Friday, November 10th. Investors of record on Friday, September 29th will be paid a $0.95 dividend. This represents a $3.80 dividend on an annualized basis and a yield of 4.92%. The ex-dividend date is Thursday, September 28th. National Health Investors’s payout ratio is currently 97.69%.
In related news, insider Kevin Carlton Pascoe sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $79.80, for a total value of $159,600.00. Following the sale, the insider now owns 21,228 shares of the company’s stock, valued at approximately $1,693,994.40. The transaction was disclosed in a filing with the SEC, which is available through this link. 5.19% of the stock is currently owned by corporate insiders.
A number of hedge funds have recently bought and sold shares of the stock. Coldstream Capital Management Inc. lifted its stake in National Health Investors by 18.7% in the 2nd quarter. Coldstream Capital Management Inc. now owns 8,225 shares of the real estate investment trust’s stock valued at $651,000 after buying an additional 1,298 shares in the last quarter. The Manufacturers Life Insurance Company lifted its stake in National Health Investors by 2.8% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 29,691 shares of the real estate investment trust’s stock valued at $2,352,000 after buying an additional 798 shares in the last quarter. State Street Corp lifted its stake in National Health Investors by 8.5% in the 2nd quarter. State Street Corp now owns 999,167 shares of the real estate investment trust’s stock valued at $79,133,000 after buying an additional 78,355 shares in the last quarter. Janus Henderson Group PLC lifted its stake in National Health Investors by 59.5% in the 2nd quarter. Janus Henderson Group PLC now owns 13,956 shares of the real estate investment trust’s stock valued at $1,105,000 after buying an additional 5,206 shares in the last quarter. Finally, Employees Retirement System of Texas lifted its stake in National Health Investors by 353.3% in the 2nd quarter. Employees Retirement System of Texas now owns 81,600 shares of the real estate investment trust’s stock valued at $6,463,000 after buying an additional 63,600 shares in the last quarter. 70.67% of the stock is currently owned by hedge funds and other institutional investors.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.